United States - English - NLM (National Library of Medicine)

covetrus - xylazine hydrochloride (unii: ngc3s0882s) (xylazine - unii:2kfg9tp5v8) - indications xylazine should be used in horses and cervidae (fallow deer, mule deer, sika deer, white-tailed deer, and elk) when it is desirable to produce a state of sedation accompanied by a shorter period of analgesia. horses: xylazine has been used successfully as follows: 1.  diagnostic procedures-oral and ophthalmic examinations, abdominal palpation, rectal palpation, vaginal examination, catheterization of the bladder and radiographic examinations. 2.  orthopedic procedures, such as application of casting materials and splints. 3.  dental procedures. 4.  minor surgical procedures of short duration such as debridement, removal of cutaneous neoplasms and suturing of lacerations. 5.  to calm and facilitate handling of fractious animals. 6.  therapeutic medication for sedation and relief of pain following injury or surgery. 7.  major surgical procedures:       a.when used as a preanesthetic to general anesthesia.       b.when used in conjunction with local anesthetics. cervidae: xylazine may be used for the following: 1.  to calm and facilitate handling of fractious animals. 2.  diagnostic procedures. 3.  minor surgical procedures. 4.  therapeutic medication for sedation and relief of pain following injury or surgery. 5.  as a preanesthetic to local anesthesia. xylazine at the recommended dosages can be used in conjunction with local anesthetics, such as procaine or lidocaine.

Ireland - English - HPRA (Health Products Regulatory Authority)

exeltis healthcare s.l. - doxylamine; pyridoxine hydrochloride - gastro-resistant tablet - 10/10 milligram(s) - doxylamine, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

exeltis healthcare s.l. - doxylamine hydrogen succinate; pyridoxine hydrochloride - modified-release tablet - doxylamine, combinations

Malta - English - Medicines Authority

krka dd novo mesto Šmarješka cesta 6, 8501 novo mesto, slovenia - doxylamine succinate - film-coated tablet - doxylamine succinate 15 mg - antihistamines for systemic use

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - xylazine as the hydrochloride - parenteral liquid/solution/suspension - xylazine as the hydrochloride thiazole active 100.0 mg/ml - central nervous system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - analgesic | muscle relaxant | anaesthetic | antipyretic | colic | general anaesthetic | muscle relaxant | muscular spasms | parasympatholytic agent | sedative | spasmolytic | strychnine poisoning

United States - English - NLM (National Library of Medicine)

attix pharmaceuticals - xylazine hydrochloride (unii: ngc3s0882s) (xylazine - unii:2kfg9tp5v8) - xylazine hydrochloride 1 kg in 1 kg

Canada - English - Health Canada

boehringer ingelheim (canada) ltd ltee - xylazine (xylazine hydrochloride) - liquid - 100mg - xylazine (xylazine hydrochloride) 100mg - horses

United States - English - NLM (National Library of Medicine)

par pharmaceutical, inc. - doxylamine succinate (unii: v9bi9b5yi2) (doxylamine - unii:95qb77jkpl), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z) - doxylamine succinate and pyridoxine hydrochloride delayed-release tablets are indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.   limitations of use doxylamine succinate and pyridoxine hydrochloride delayed-release tablet has not been studied in women with hyperemesis gravidarum.   doxylamine succinate and pyridoxine hydrochloride is contraindicated in women with any of the following conditions:   - known hypersensitivity to doxylamine succinate, other ethanolamine derivative antihistamines, pyridoxine hydrochloride or any inactive ingredient in the formulation monoamine oxidase (mao) inhibitors intensify and prolong the adverse central nervous system effects of doxylamine succinate and pyridoxine hydrochloride [see drug interactions (7.1)].  risk summary doxylamine succinate and pyridoxine hydrochloride is intended for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management. maternal risks a

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - doxylamine succinate (unii: v9bi9b5yi2) (doxylamine - unii:95qb77jkpl), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z) - doxylamine succinate and pyridoxine hydrochloride delayed-release tablets are indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management. limitations of use doxylamine succinate and pyridoxine hydrochloride delayed-release tablets have not been studied in women with hyperemesis gravidarum. doxylamine succinate and pyridoxine hydrochloride delayed-release tablets are contraindicated in women with any of the following conditions: - known hypersensitivity to doxylamine succinate, other ethanolamine derivative antihistamines, pyridoxine hydrochloride or any inactive ingredient in the formulation - monoamine oxidase (mao) inhibitors intensify and prolong the adverse central nervous system effects of doxylamine succinate and pyridoxine hydrochloride delayed-release tablets [see drug interactions (7.1) ] . risk summary doxylamine succinate and pyridoxine hydrochloride delayed-release tablets are intended for the treatment of nausea and vomiting of pregnanc

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

4 farmers australia pty ltd - terbuthylazine - water dispersible granule - terbuthylazine triazine active 750.0 g/kg - herbicide